A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 81,612 shares of TXG stock, worth $1.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
81,612
Previous 63,892 27.73%
Holding current value
$1.6 Million
Previous $3.58 Million 14.35%
% of portfolio
0.02%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$36.08 - $54.3 $639,337 - $962,196
17,720 Added 27.73%
81,612 $3.06 Million
Q4 2023

Feb 14, 2024

BUY
$34.32 - $57.55 $1.7 Million - $2.85 Million
49,609 Added 347.33%
63,892 $3.58 Million
Q3 2023

Nov 15, 2023

SELL
$40.86 - $62.98 $6.41 Million - $9.87 Million
-156,789 Reduced 91.65%
14,283 $589,000
Q2 2023

Aug 14, 2023

BUY
$50.96 - $58.72 $6.6 Million - $7.6 Million
129,417 Added 310.69%
171,072 $9.55 Million
Q1 2023

May 15, 2023

BUY
$35.33 - $55.79 $212,262 - $335,186
6,008 Added 16.85%
41,655 $2.32 Million
Q4 2022

Feb 14, 2023

BUY
$24.4 - $41.3 $869,786 - $1.47 Million
35,647 New
35,647 $1.3 Million
Q2 2022

Aug 15, 2022

BUY
$36.95 - $82.41 $1.59 Million - $3.56 Million
43,165 Added 108.37%
82,997 $3.76 Million
Q1 2022

May 16, 2022

BUY
$55.7 - $145.79 $2.22 Million - $5.81 Million
39,832 New
39,832 $3.03 Million
Q1 2021

May 17, 2021

SELL
$140.25 - $196.86 $718,360 - $1.01 Million
-5,122 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$126.47 - $163.7 $5.84 Million - $7.56 Million
-46,174 Reduced 90.01%
5,122 $725,000
Q3 2020

Nov 16, 2020

BUY
$87.44 - $125.0 $4.49 Million - $6.41 Million
51,296 New
51,296 $6.4 Million
Q4 2019

Feb 14, 2020

SELL
$46.07 - $79.54 $523,723 - $904,210
-11,368 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$49.99 - $62.0 $568,286 - $704,816
11,368 New
11,368 $573,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.86B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.